News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Celgene Corporation (CELG) Reports First Quarter 2014 Operating And Financial Results


4/24/2014 7:32:14 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Celgene Corporation (NASDAQ:CELG) reported net product sales of $1,708 million for the first quarter of 2014, a 19 percent increase from the same period in 2013. First quarter total revenue increased 18 percent to $1,730 million compared to $1,465 million in the first quarter of 2013. Adjusted net income for the first quarter of 2014 increased 19 percent to $705 million compared to $592 million in the first quarter of 2013. For the same period, adjusted diluted earnings per share increased 22 percent to $1.67 from $1.37.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES